ArticleThe Journal of clinical endocrinology and metabolism2025

Semaglutide Reprograms Macrophages via the GLP-1R/PPARG/ACSL1 Pathway to Suppress Papillary Thyroid Carcinoma Growth.

Longlong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.